INCY Barry P Flannelly sells $1.3M worth of shares
Mar 19, 2025, 4:32 AM
0.00%
What does INCY do
Yte is a Wilmington, Delaware-based biopharmaceutical company with 2,524 employees, focusing on hematology/oncology and inflammation/autoimmunity therapeutic areas. Its product portfolio includes JAKAFI, MONJUVI, and PEMAZYRE, among others.
Barry P Flannelly sold 19,807 shares of INCY on 14 March at $67.68 per share, worth a total of $1.3M. They now own 52,913 INCY shares, or a 37% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
